United StatesWegovy (semaglutide) Injection 0.5 mg/0.5 mL and 1 mg/0.5 mL, sold as boxes of four single‑dose prefilled pens (NDC 0169‑4505‑14 and 0169‑4501‑14) manufactured by Novo Nordisk A/S and distributed by Novo Nordisk Inc., lot RZFHD52 and RZFHW93 (exp. 10/31/2026) and lot RZFYK06 and RZFYA53 (exp. 3/31/2027) sold nationwide in the United States are affected. They were recalled for presence of particulate matter after a hair was found in a prefilled syringe.
What's being recalled
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Recalling firm: Novo Nordisk Inc., Plainsboro, NJ, United States.
How to identify it
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026 Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
The hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the United States.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)